200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 694433-59-5
694433-59-5 | 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride
CAS No: 694433-59-5 Catalog No: AG00FC10 MDL No:MFCD20926329
Product Description
Catalog Number:
AG00FC10
Chemical Name:
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride
CAS Number:
694433-59-5
Molecular Formula:
C20H21N3O2
Molecular Weight:
335.3996
MDL Number:
MFCD20926329
IUPAC Name:
2-[4-(1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine
InChI:
InChI=1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23)
InChI Key:
WGZOTBUYUFBEPZ-UHFFFAOYSA-N
SMILES:
Cc1cccc(n1)c1[nH]c(nc1c1ccc2c(c1)OCO2)C(C)(C)C
Properties
Complexity:
466
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
335.163g/mol
Formal Charge:
0
Heavy Atom Count:
25
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
335.407g/mol
Monoisotopic Mass:
335.163g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
60A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.3
Literature
| Title | Journal |
|---|---|
| Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent. | Journal of medicinal chemistry 20140522 |
| A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. | The Biochemical journal 20130415 |
| NODAL and SHH dose-dependent double inhibition promotes an HPE-like phenotype in chick embryos. | Disease models & mechanisms 20130301 |
| Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis. | Kidney international 20121001 |
| Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. | Molecular cancer therapeutics 20121001 |
| Yin-Yang1 is required for epithelial-to-mesenchymal transition and regulation of Nodal signaling during mammalian gastrulation. | Developmental biology 20120815 |
| Transforming growth factor-β2 induces synthesis and secretion of endothelin-1 in human trabecular meshwork cells. | Investigative ophthalmology & visual science 20120807 |
| Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. | Nature biotechnology 20111101 |
| Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors. | European journal of medicinal chemistry 20110901 |
| Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors. | Bioorganic & medicinal chemistry 20110415 |
| Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification. | Tissue engineering. Part A 20110401 |
| Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors. | Bioorganic & medicinal chemistry letters 20100715 |
| Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-beta type 1 receptor kinase inhibitors. | Bioorganic & medicinal chemistry 20100615 |
| Hydrogen sulfide attenuates epithelial-mesenchymal transition of human alveolar epithelial cells. | Pharmacological research 20100401 |
| Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor. | Molecular vision 20100101 |
| Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5). | Bioorganic & medicinal chemistry letters 20090815 |
| TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway. | Biochemical and biophysical research communications 20080711 |
| The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. | Gastroenterology 20080601 |
| TGF-beta signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury. | American journal of physiology. Lung cellular and molecular physiology 20080401 |
| Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-beta type1 receptor kinase inhibitors. | Bioorganic & medicinal chemistry letters 20080315 |
| The role of maternal Activin-like signals in zebrafish embryos. | Developmental biology 20070915 |
| Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors. | Journal of medicinal chemistry 20070628 |
| Time-dependent patterning of the mesoderm and endoderm by Nodal signals in zebrafish. | BMC developmental biology 20070101 |
| SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. | Molecular pharmacology 20040301 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.